The team from Four 20 Pharma (Four 20) attended Expopharm 2025 (16th-18th September), Europe’s largest trade fair for the pharmacy market hosted in Düsseldorf.
At the event, the team launched the Curaleaf Que Medical Inhalation Device (QMID), the first medically certified liquid inhaler for delivery of medical cannabis.
It was a strong statement at this year’s Expopharm and brought the device into the forefront for pharmacists, doctors, pharmacy technicians, and industry partners also at the event.
The release of the QMID device and strong feedback is an exciting and clear example of how Curaleaf is shaping the future of medical cannabis.
Here is a video from the event, capturing the success and response.
